News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Amryt Pharma plc
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
April 12, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
April 03, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
March 22, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
February 16, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
January 08, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH
January 05, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
December 19, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
European Commission approves Mycapssa® for the treatment of Acromegaly
December 05, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Announces New Patent for Mycapssa®
November 30, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Reports Q3 2022 Financial and Operational Results
November 03, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Supports Acromegaly Awareness Day 2022
October 31, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa
October 25, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Supports Global EB Awareness Week 2022
October 24, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt to Report Q3 2022 Results on November 3, 2022
October 19, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly
October 18, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)
October 17, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Tickers
AMYT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close